Home

Sms Lifesciences India Ltd PE Ratio

Image

SMS Lifesciences India Ltd

NSE: SMSLIFE

PE

15.2

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of SMS Lifesciences India Ltd is 15.2 as of 22 Feb 12:11 PM .
  • The P/E Ratio of SMS Lifesciences India Ltd changed from 5.2 on March 2020 to 22.6 on March 2024 . This represents a CAGR of 34.16% over 5 years.
  • The Latest Trading Price of SMS Lifesciences India Ltd is ₹ 1155 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of SMS Lifesciences India Ltd

No data available

Company Fundamentals for SMS Lifesciences India Ltd

Image

SMS Lifesciences India Ltd

NSE: SMSLIFE

Share Price

₹ 1155.25

-59.70 (-4.91%)

stock direction

Last updated on: Feb 21, 2025

Market Price of SMS Lifesciences India Ltd

1M

1Y

3Y

5Y

Monitoring SMS Lifesciences India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 20251155.25
20 Feb 20251214.95
19 Feb 20251230.6
18 Feb 20251172
17 Feb 20251206
14 Feb 20251265.55
13 Feb 20251270
12 Feb 20251223.65
11 Feb 20251288.05
10 Feb 20251311.95

SWOT Analysis Of SMS Lifesciences India Ltd

Strength

3

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for SMS Lifesciences India Ltd

Asset Value vs Market Value of SMS Lifesciences India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
SMS Lifesciences India Ltd349.27
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of SMS Lifesciences India Ltd Explained

349.27

Market cap

23

Earnings

15.2X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of SMS Lifesciences India Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of SMS Lifesciences India Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of SMS Lifesciences India Ltd

No data available

* All values are in %

About SMS Lifesciences India Ltd

  • SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
  • The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
  • The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
  • The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

SMS Lifesciences India Ltd News Hub

SMS LifeSciences India AGM scheduled

SMS LifeSciences India announced that the 18th Annual General Meeting (AGM) of the company will be h

Read more

20 Aug 24

SMS Lifesciences India reports consolidated net profit of Rs 7.00 crore in the June 2024 quarter

Net profit of SMS Lifesciences India reported to Rs 7.00 crore in the quarter ended June 2024 as aga

Read more

09 Aug 24

SMS LifeSciences India schedules board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 9 August 2024

Read more

08 Aug 24

SMS LifeSciences India to conduct board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 13 November 2

Read more

09 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of SMS Lifesciences India Ltd

What is the current PE Ratio of SMS Lifesciences India Ltd?

The Current PE Ratio of SMS Lifesciences India Ltd is 15.16 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of SMS Lifesciences India Ltd last year?

The PE Ratio of SMS Lifesciences India Ltd was 13.72 last year, now the PE ratio is 15.16, showing a year-on-year growth of 10.5%.

What does the PE Ratio of SMS Lifesciences India Ltd indicate about its stock?

The PE Ratio of SMS Lifesciences India Ltd is 15.16. This ratio indicates that investors are willing to pay 15.16 times the earnings per share for each share of SMS Lifesciences India Ltd.

What is the PE Ratio Growth of SMS Lifesciences India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of SMS Lifesciences India Ltd grew by 10.5% whereas, the EPS ratio grew by 16.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions